AZAINDAZOLE AMIDE COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS
申请人:Boehringer Ingelheim International GmbH
公开号:EP2563787B1
公开(公告)日:2014-11-26
Azaindazole Amide Compounds As CCR1 Receptor Antagonists
申请人:Huber John D.
公开号:US20130203803A1
公开(公告)日:2013-08-08
Disclosed are CCR1 inhibitor compounds of the formula (I): which are useful in the treatment of autoimmune and other diseases. Also disclosed a pharmaceutical compositions containing the same, and methods of making and using same.